Ordr
Device Security PlatformsHTMwire assessment
AI-powered medical device discovery and security with behavioral modeling, automated microsegmentation, and Zero Trust policy for healthcare.
Key Features
- ✓ AI-enhanced device discovery for IoMT, IoT, OT, and IT devices
- ✓ Flow Genome ML engine for behavioral profiling and baselining
- ✓ Patented automated microsegmentation policy generation
- ✓ ORDR IQ for automated ticketing, vulnerability response, and compliance artifacts
- ✓ Three U.S. patents for device classification and segmentation
What It Helps You Do
What Sets Them Apart
Three U.S. patents for device classification and automated segmentation — only platform that generates clinically-safe microsegmentation policies validated against real device behavior.
How Ordr Uses AI
HTMwire's independent read on the technology — not the vendor's marketing claim.
Flow Genome uses ML to profile every device's behavior and baseline communication patterns. ORDR IQ uses AI to automate ticketing, vulnerability response coordination, and compliance artifact generation from verified telemetry data.
- ML device profiling. Systems Control Engine combines deep packet inspection and machine learning to classify devices and baseline behavior.
- Automated policy generation. Generates microsegmentation policies from observed device communication patterns to limit lateral movement.
Key Numbers
- ▪ Insights from 100M+ connected devices
- ▪ $40M Series C (June 2022); $90M+ raised to date
Integrations
Tags
Featured In
Trust Signals
Frequently Asked Questions
How does Ordr discover and profile connected devices?
Ordr's Systems Control Engine uses deep packet inspection plus machine learning to passively discover every IoT, IoMT, OT, and IT device, profile its risk and behavior, map its communications, and generate automated segmentation policies.
Does Ordr integrate with our existing CMMS and security stack?
Ordr is designed to feed device data into existing tools and is commonly integrated with ServiceNow, Cisco ISE, Palo Alto Networks, CrowdStrike, and Accruent TMS, though specific connector availability should be confirmed with Ordr for your environment.
Who backs Ordr and does it have healthcare credibility?
Ordr had raised more than $90M as of its $40M Series C (June 2022), co-led by Battery Ventures and Ten Eleven Ventures. Healthcare strategic investors include Kaiser Permanente Ventures and Mayo Clinic, signaling provider-side validation of its IoMT focus.
How many devices has Ordr's platform observed?
Ordr's platform draws insights from more than 100 million connected devices, according to investor Ten Eleven Ventures, which informs its device classification and behavioral baselining.
Sources
- Ordr secures $40M Series C; $90M+ raised, investors named
- Ten Eleven Ventures portfolio: Ordr (100M+ devices, co-founder)
- Industrial Cyber: Ordr $40M funding round
We cite a primary or named source for every claim on this page. How we evaluate →